These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36577836)

  • 1. Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer.
    Ma HW; Kim JM; Kim DH; Park IS; Kim JH; Park KC; Seo DH; Kim JH; Che X; Kim TI; Cheon JH; Kim SW
    Cancer Gene Ther; 2023 May; 30(5):694-703. PubMed ID: 36577836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
    Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
    J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
    Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
    Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking NFATc3 ameliorates azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer in mice via the inhibition of inflammatory responses and epithelial-mesenchymal transition.
    Lin Y; Koumba MH; Qu S; Wang D; Lin L
    Cell Signal; 2020 Oct; 74():109707. PubMed ID: 32653643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
    Yu L; Wang L; Chen S
    Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes.
    Park KS; Kim KK; Piao ZH; Kim MK; Lee HJ; Kim YC; Lee KS; Lee JH; Kim KE
    Mol Cells; 2012 Dec; 34(6):555-61. PubMed ID: 23161172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.
    Chen L; Li H; Liu W; Zhu J; Zhao X; Wright E; Cao L; Ding I; Rodgers GP
    Carcinogenesis; 2011 Jul; 32(7):986-94. PubMed ID: 21470957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
    Liu W; Geng C; Li X; Li Y; Song S; Wang C
    Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
    Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
    Front Immunol; 2020; 11():980. PubMed ID: 32670264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
    Lin L; Wang D; Qu S; Zhao H; Lin Y
    Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.
    Kim BR; Oh SC; Lee DH; Kim JL; Lee SY; Kang MH; Lee SI; Kang S; Joung SY; Min BW
    Tumour Biol; 2015 Dec; 36(12):9475-86. PubMed ID: 26124007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.